Lupin Q3 net up 4.95 per cent at Rs 235.1 crore
Drug firm Lupin said its consolidated net profit rose by 4.95%to Rs 235.1 crore for the third quarter ended December 31, 2011, over the same period last fiscal.
By PTI | Updated:
NEW DELHI: Drug firm Lupin today said that its consolidated net profit rose by 4.95 per cent to Rs 235.1 crore for the third quarter ended December 31, 2011, over the same period last fiscal.
The company had posted a net profit of Rs 224 crore for the corresponding period of previous fiscal.
Net sales of the company grew by 21.9 per cent to Rs 1,791.7 crore for the third quarter, compared to Rs 1,469.4 crore in the same period previous fiscal.
Shares of Lupin were trading at Rs 448.45 on the BSE in the late afternoon trade, up 2.51 per cent from its previous close.
The company had posted a net profit of Rs 224 crore for the corresponding period of previous fiscal.
Net sales of the company grew by 21.9 per cent to Rs 1,791.7 crore for the third quarter, compared to Rs 1,469.4 crore in the same period previous fiscal.
Shares of Lupin were trading at Rs 448.45 on the BSE in the late afternoon trade, up 2.51 per cent from its previous close.
Too busy to trade in stocks? Invest in Mutual Funds with ET Money!
Bookmark or read stories offline -
Download ET Markets APP
Download ET Markets APP
ADVERTISEMENT
